U S Physical Therapy Inc /nv (USPH): Lawrance W Mcafee , Chief Financial Officer of U S Physical Therapy Inc /nv sold 2,000 shares on Jun 10, 2016. The Insider selling transaction was reported by the company on Jun 13, 2016 to the Securities and Exchange Commission. The shares were sold at $59.27 per share for a total value of $118,540.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 25, 2016, Bernard A Jr Harris (director) sold 2,912 shares at $19.75 per share price.On May 24, 2016, Regg E. Swanson (director) sold 3,000 shares at $57.29 per share price.Also, On May 12, 2016, Christopher J Reading (Chief Executive Officer) sold 15,000 shares at $57.82 per share price.On May 11, 2016, Glenn Mcdowell (Chief Operating Officer) sold 8,354 shares at $57.95 per share price.
Shares of U.S. Physical Therapy (USPH) ended Friday, Jun 10, 2016 session in red amid volatile trading. The shares closed down -0.25 points or -0.42% at $59.4 with 48,226 shares getting traded. Post opening the session at $59.33, the shares hit an intraday low of $58.975 and an intraday high of $60.46 and the price vacillated in this range throughout the day. The company has a market cap of $743 M and the number of outstanding shares has been calculated to be 1,25,02,726 shares. The 52-week high of U.S. Physical Therapy is $60.59 and the 52-week low is $42.59.
Company has been under the radar of several Street Analysts.U.S. Physical Therapy is Upgraded by Barrington Research to Outperform and the brokerage firm has set the Price Target at $58. Earlier the firm had a rating of Mkt Perform on the company shares. The Rating was issued on May 6, 2016.
U.S. Physical Therapy Inc. through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders sports-related injuries preventative care rehabilitation of injured workers and neurological-related injuries. The Company primarily operates through subsidiary clinic partnerships in which it owns a 1% general partnership interest and a 64% limited partnership interest and the managing therapists of the clinics owns the remaining limited partnership interest in the clinics. The Company provides services at its clinics on an outpatient basis. Patients are treated for approximately one hour per day two to three times a week for two to six weeks. The Company operates approximately 489 clinics in 42 states of the United States.